The Net Margin of AptaBio Therapeutics Inc (293780.KQ) is -874.09%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -874.09% |
| 2023-12-31 | -3724.24% |
| 2022-12-31 | -21849.25% |
| 2021-12-31 | -4778.80% |
| 2020-12-31 | -1149.24% |
| 2019-12-31 | -618.29% |
| 2018-12-31 | -279.42% |
| 2017-12-31 | -10370.78% |